Chee Fu Yung
Overview
Explore the profile of Chee Fu Yung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1429
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Yung C, Kam K, Nadua K, Tan N, Thoon K, et al.
Open Forum Infect Dis
. 2025 Mar;
12(3):ofaf093.
PMID: 40046886
Background: Data on burden of invasive pneumococcal disease (IPD) are lacking from Southeast Asia. With the introduction of higher-valency pneumococcal conjugate vaccines (PCVs), we aim to assess the impact of...
2.
Zhao C, Zhang T, Guo L, Sun S, Miao Y, Yung C, et al.
Nat Commun
. 2025 Feb;
16(1):1610.
PMID: 39948338
The COVID-19 pandemic and relevant non-pharmaceutical interventions (NPIs) interrupted the circulation of common respiratory viruses. These viruses demonstrated an unprecedented asynchronous resurgence as NPIs were relaxed. We compiled a global...
3.
Kong C, Tan N, Nadua K, Kam K, Li J, Thoon K, et al.
J Paediatr Child Health
. 2024 Oct;
61(1):39-46.
PMID: 39440692
Aim: Continuous monitoring of blood culture (BC) systems allows rapid detection of microbial growth. We aimed to determine differences in time to positivity (TTP) in BACTEC BC between organisms and...
4.
Tan C, Zhu F, Chia W, Young B, Yeoh A, Althaus T, et al.
Hlife
. 2024 Jul;
1(1):26-34.
PMID: 38994526
Multiple Omicron sub-lineages have emerged, with Omicron XBB and XBB.1.5 subvariants becoming the dominant variants globally at the time of this study. The key feature of new variants is their...
5.
Roy Chowdhury S, Nadua K, Li J, Kam K, Thoon K, Tan N, et al.
Ann Acad Med Singap
. 2024 Jul;
53(6):390-395.
PMID: 38979995
No abstract available.
6.
Lim A, Low J, Tan M, Ngeow A, Tong W, Chua K, et al.
Ann Acad Med Singap
. 2024 Jun;
53(1):53-56.
PMID: 38920216
No abstract available.
7.
Li J, Nadua K, Chong C, Yung C
Ann Acad Med Singap
. 2024 Jun;
52(10):522-532.
PMID: 38920203
Introduction: Information on the quality of health of children and younger persons (CYPs) after SARS-COV-2 infection remains scarce, especially from Asia. In this study, we utilised an online survey to...
8.
Qui M, Hariharaputran S, Hang S, Zhang J, Tan C, Chong C, et al.
EBioMedicine
. 2024 Jun;
105:105203.
PMID: 38896919
Background: Hybrid immunity to SARS-CoV-2, resulting from both vaccination and natural infection, remains insufficiently understood in paediatric populations, despite increasing rates of breakthrough infections among vaccinated children. Methods: We conducted...
9.
Cheung Y, Ma X, Lam K, Yung C, Milligan P
Stat Med
. 2024 Feb;
43(9):1759-1773.
PMID: 38396234
In studies of infectious disease prevention, the level of protective efficacy of medicinal products such as vaccines and prophylactic drugs tends to vary over time. Many products require administration of...
10.
Cong B, Koc U, Bandeira T, Bassat Q, Bont L, Chakhunashvili G, et al.
Lancet Infect Dis
. 2023 Dec;
24(4):361-374.
PMID: 38141633
Background: The COVID-19 pandemic is reported to have affected the epidemiology of respiratory syncytial virus (RSV), which could have important implications for RSV prevention and control strategies. We aimed to...